With the analysis among 2,747 patents, we discovered top 377 key players by total patent application. Genzyme Corp., BioMarin Pharmaceutical, Inc., Shire Human Genetic Therapies, Inc. are dominant in this area. They take 20.17% of the total patent filing.
Massachusetts, United States
Patent: 220
BioMarin Pharmaceutical, Inc.
California, United States
Patent: 170
Shire Human Genetic Therapies, Inc.
Massachusetts, United States
Patent: 164
Amicus Therapeutics, Inc.
New Jersey, United States
Patent: 139
Prevail Therapeutics, Inc.
New York, United States
Patent: 89
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 69
JCR Pharmaceuticals Co., Ltd.
Hokkaido, Japan
Patent: 44
Alexion Pharmaceuticals, Inc.
Connecticut, United States
Patent: 37
With the analysis among 201 patents, we discovered top 17 start-ups by total patent application. Prevail Therapeutics, Inc., IntraBio Ltd., Institut National de la Santé et de la Recherche Médicale are active in this area.
Prevail Therapeutics, Inc.
New York, United States
Patent: 89
Institut National de la Santé et de la Recherche Médicale
California, United States
Patent: 9
Massachusetts, United States
Patent: 8
New York, United States
Patent: 8
Nordrhein-Westfalen, Germany
Patent: 6
Missouri, United States
Patent: 3
LogicBio Therapeutics, Inc.
California, United States
Patent: 2
With the analysis among related 1,796 patents applied in the last 5 years. We discover 486 most active companies in this area. The fast-growing Prevail Therapeutics, Inc., Genzyme Corp., Regeneron Pharmaceuticals, Inc. take 10.86% of patent filing during this period.
Prevail Therapeutics, Inc.
New York, United States
Patent: 89
Massachusetts, United States
Patent: 55
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 51
Amicus Therapeutics, Inc.
New Jersey, United States
Patent: 38
Tokyo-to, Japan
Patent: 31
Shire Human Genetic Therapies, Inc.
Massachusetts, United States
Patent: 30
Alectos Therapeutics, Inc.
British Columbia, Canada
Patent: 29
Regents of the University of California
California, United States
Patent: 27
JCR Pharmaceuticals Co., Ltd.
Hokkaido, Japan
Patent: 23
Denali Therapeutics, Inc.
California, United States
Patent: 23
With the analysis among related 1,796 patents in last 5 years, we discover 318 new entrants. Prevail Therapeutics, Inc., Alectos Therapeutics, Inc., Denali Therapeutics, Inc. are the most active new entrants in this area.
Prevail Therapeutics, Inc.
New York, United States
Patent: 89
Alectos Therapeutics, Inc.
British Columbia, Canada
Patent: 29
Denali Therapeutics, Inc.
California, United States
Patent: 23
Asklepios BioPharmaceutical, Inc.
North Carolina, United States
Patent: 19
Fondazione Istituto Italiano di Tecnologia
Georgetown University School of Medicine
District of Columbia, United States
Patent: 13
Massachusetts, United States
Patent: 11
BIAL-Biotech Investments, Inc.
Massachusetts, United States
Patent: 10
With the analysis among 1,508 patents, we discovered top 267 universities and scientific research institutions by total patent application. Autonomous University of Barcelona, Icahn School of Medicine at Mount Sinai, Duke University are dominant in this area. They take 8.22% of the total patent filing.
Autonomous University of Barcelona
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 35
North Carolina, United States
Patent: 34
University of Massachusetts
Massachusetts, United States
Patent: 34
Western Australia, Australia
Patent: 26
Shandong Sheng, China
Patent: 22
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 21
Washington, United States
Patent: 20
Missouri, United States
Patent: 19
Zhejiang Sheng, China
Patent: 19